Atossa Therapeutics (ATOS) Stock Chart & Stock Price History $1.41 -0.01 (-0.70%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Atossa Therapeutics Stock Price Performance5 Day Performance+2.17%1 Month Performance-4.08%3 Month Performance+22.61%6 Month Performance-15.06%Year-To-Date Performance+60.23%1 Year Performance+101.43% Receive ATOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> ATOS Stock Chart for Tuesday, November, 5, 2024 ATOS Chart by TradingView Atossa Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$1.42$1.41-0.70%$1.43$1.36676,637 shs$177.32 million11/01/2024$1.38$1.42+2.90%$1.44$1.38590,709 shs$178.58 million10/31/2024$1.41$1.38-2.13%$1.42$1.36636,296 shs$173.55 million10/30/2024$1.43$1.41-1.40%$1.43$1.41363,051 shs$177.32 million10/29/2024$1.45$1.43-1.38%$1.44$1.42418,237 shs$179.83 million10/28/2024$1.42$1.45+2.11%$1.47$1.42372,157 shs$182.35 million Get the Latest News and Ratings for ATOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$1.41$1.42+0.71%$1.46$1.42251,108 shs$178.58 million10/24/2024$1.46$1.41-3.42%$1.47$1.40497,667 shs$177.32 million10/23/2024$1.50$1.46-2.67%$1.50$1.45315,637 shs$183.61 million10/22/2024$1.45$1.50+3.45%$1.50$1.43366,534 shs$188.64 million10/21/2024$1.45$1.45$1.47$1.43353,603 shs$182.35 million10/18/2024$1.45$1.45$1.46$1.44221,645 shs$182.35 million10/17/2024$1.47$1.45-1.36%$1.47$1.43265,805 shs$182.35 million10/16/2024$1.43$1.47+2.80%$1.48$1.42607,638 shs$184.86 million10/15/2024$1.42$1.43+0.70%$1.44$1.34471,704 shs$179.83 million10/14/2024$1.44$1.42-1.39%$1.43$1.40382,570 shs$178.58 million10/11/2024$1.39$1.44+3.60%$1.44$1.37357,218 shs$181.09 million10/10/2024$1.40$1.39-0.71%$1.41$1.36378,744 shs$174.80 million10/09/2024$1.42$1.40-1.41%$1.43$1.38496,899 shs$176.06 million10/08/2024$1.42$1.42$1.45$1.41251,562 shs$178.58 million10/07/2024$1.47$1.42-3.40%$1.47$1.42487,173 shs$178.58 million10/04/2024$1.41$1.47+4.26%$1.48$1.43439,313 shs$184.86 million10/03/2024$1.47$1.41-4.08%$1.48$1.40511,829 shs$177.32 million10/02/2024$1.46$1.47+0.68%$1.48$1.43445,472 shs$184.86 million10/01/2024$1.52$1.46-3.95%$1.52$1.46454,481 shs$183.61 million09/30/2024$1.51$1.52+0.66%$1.58$1.49710,257 shs$191.15 million09/27/2024$1.39$1.51+8.63%$1.51$1.40894,702 shs$189.89 million09/26/2024$1.39$1.39$1.43$1.37570,824 shs$174.80 million09/25/2024$1.40$1.39-0.71%$1.42$1.35271,046 shs$174.81 million09/24/2024$1.41$1.40-0.71%$1.44$1.38457,312 shs$176.06 million09/23/2024$1.46$1.41-3.42%$1.48$1.40433,594 shs$177.32 million09/20/2024$1.46$1.46$1.51$1.381.29 million shs$183.61 million09/19/2024$1.42$1.46+2.82%$1.51$1.43675,236 shs$183.61 million09/18/2024$1.45$1.42-2.07%$1.47$1.39502,328 shs$178.58 million09/17/2024$1.51$1.45-3.97%$1.52$1.41584,345 shs$182.35 million09/16/2024$1.52$1.51-0.66%$1.55$1.50491,946 shs$189.90 million09/13/2024$1.50$1.52+1.33%$1.54$1.49499,220 shs$191.16 million09/12/2024$1.52$1.50-1.32%$1.54$1.47507,948 shs$188.64 million09/11/2024$1.46$1.52+4.11%$1.52$1.44762,274 shs$191.16 million09/10/2024$1.36$1.46+7.35%$1.48$1.34884,693 shs$183.61 millionUnveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>>09/09/2024$1.33$1.36+2.26%$1.38$1.32469,702 shs$171.03 million09/06/2024$1.36$1.33-2.21%$1.37$1.31321,583 shs$167.26 million09/05/2024$1.36$1.36$1.37$1.33343,600 shs$171.03 million09/04/2024$1.34$1.36+1.49%$1.38$1.29398,868 shs$171.03 million09/03/2024$1.37$1.34-2.19%$1.40$1.33460,367 shs$168.51 million09/02/2024$1.37$1.37$1.40$1.33558,800 shs$172.29 million08/30/2024$1.37$1.37$1.40$1.33558,658 shs$172.29 million08/29/2024$1.38$1.37-0.72%$1.46$1.36872,139 shs$172.29 million08/28/2024$1.35$1.38+2.22%$1.40$1.34435,424 shs$173.55 million08/27/2024$1.45$1.35-6.90%$1.43$1.33806,501 shs$169.77 million08/26/2024$1.42$1.45+2.11%$1.45$1.41658,342 shs$182.35 million08/23/2024$1.37$1.42+3.65%$1.42$1.37581,094 shs$178.58 million08/22/2024$1.39$1.37-1.44%$1.39$1.35279,584 shs$172.29 million08/21/2024$1.34$1.39+3.73%$1.39$1.31588,679 shs$174.80 million08/20/2024$1.32$1.34+1.52%$1.35$1.30454,774 shs$168.51 million08/19/2024$1.28$1.32+3.13%$1.32$1.26478,472 shs$166.00 million08/16/2024$1.28$1.28$1.29$1.25328,095 shs$160.97 million08/15/2024$1.24$1.28+3.23%$1.32$1.25795,005 shs$160.97 million08/14/2024$1.30$1.24-4.62%$1.34$1.24387,060 shs$155.94 million08/13/2024$1.24$1.30+4.84%$1.33$1.28394,509 shs$163.48 million08/12/2024$1.17$1.24+5.98%$1.27$1.12433,422 shs$155.94 million08/09/2024$1.20$1.17-2.50%$1.22$1.17326,887 shs$147.14 million08/08/2024$1.16$1.20+3.45%$1.22$1.16449,160 shs$150.91 million08/07/2024$1.21$1.16-4.13%$1.23$1.15547,127 shs$145.88 million08/06/2024$1.15$1.21+5.22%$1.25$1.15616,081 shs$152.17 million08/05/2024$1.22$1.15-5.74%$1.20$1.101.00 million shs$144.62 million Related Companies CRMD Stock Price Chart TRML Stock Price Chart OCS Stock Price Chart ABVX Stock Price Chart ATXS Stock Price Chart YMAB Stock Price Chart STOK Stock Price Chart TRDA Stock Price Chart TNGX Stock Price Chart SLRN Stock Price Chart Receive ATOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATOS) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atossa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATOS Stock Alerts